The study provides strong clinical evidence that could drive adoption of SilverCloud by health plans and employers. While near-term revenue impact is modest, this validates the product differentiation. Monitor for partnership announcements and potential acceleration in contract wins.
How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 18 $7.60entry
- T+1 · 6mo ago +1.45%α +2.10% · $7.71
- T+5 · 6mo ago +9.08%α +7.46% · $8.29
- T+20 · 5mo ago +14.33%α +12.14% · $8.69
- T+60 · 3mo ago +62.10%α +57.52% · $12.32
Price Chart
How similar events traded
Executive Summary
Amwell announced results from a large NIH-funded randomized trial published in Nature Human Behaviour, showing SilverCloud digital behavioral health reduced mental disorder prevalence by 3.8% at two years with 74.4% participation compared to 30.2% for traditional care. This strong clinical validation strengthens Amwell's positioning in the digital mental health market.
Key Facts
- Study published in Nature Human Behaviour, one of the largest independent trials of its kind, involving 6,205 students across 26 U.S. colleges.
- Students offered SilverCloud had 74.4% participation vs. 30.2% for traditional behavioral health solutions.
- 3.8% lower prevalence of any mental disorder at two years for those receiving digital behavioral healthcare compared to screening and referral.
- Potential up to $1.18 million in avoided mental health-related costs within the study sample.
- Positive impact consistent across minoritized students and those experiencing financial stress.
Financial Impact
The study suggests up to $1.18M in avoided mental health costs within the sample, but the overall revenue impact for Amwell is indirect and depends on commercialization.
Risk Factors
- Competitive digital mental health market with many alternatives (e.g., Teladoc, Headspace).
- Slow adoption cycles in healthcare and uncertainty in reimbursement.
- Study was funded by NIH and independent; commercial replication may vary.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3296495 |
Track record
18 reports on AMWL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago DEFA14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 13, 20263d ago DEF 14A Neutral 3/10 Entry $11.74 Now $11.34 −3.41% settles Feb 11
- Nov 3, 202613d ago 8-K Neutral 5/10 Entry $12.35 Now $11.34 −8.18% settles Feb 2
- Oct 5, 20266w ago Insider Cluster Neutral 3/10 Entry $12.27 Now $11.34 −7.58% settles Dec 31
- Oct 1, 20266w ago 144 Neutral 2/10 Entry $12.39 Now $11.34 −8.47% settles Dec 29
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $12.99 Now $11.34 −12.70% settles Dec 1
- Aug 4, 202614w ago 8-K Mixed 6/10 Entry $13.02 to $14.91 Now $11.34 −12.90% ▲ +14.52% +14.32% vs SPY
- Jul 1, 202619w ago Insider Cluster Neutral 2/10 Entry $9.25 to $13.44 Now $11.34 +22.59% ▲ +45.30% +42.50% vs SPY
- Jul 1, 202619w ago 144 Neutral 2/10 Entry $9.25 to $13.47 Now $11.34 +22.59% ▲ +45.62% +42.61% vs SPY
- Jun 9, 202622w ago DEFA14A Neutral 3/10 Entry $8.50 to $12.82 Now $11.34 +33.41% ▲ +50.84% +47.02% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers